| abstract |
The present invention relates to a compound selected from the group consisting of noradrexed, triamterene, sultapride and ranunculus or a pharmaceutically acceptable salt thereof for use in the treatment and/or prevention of phenylketonuria, preferably Triamterene, noradrexed or pharmaceutically acceptable salts thereof, and combinations of said compounds with other active ingredients, relating to the use of said compounds or combinations thereof in the manufacture of a medicament for the treatment or prevention of said diseases uses, and relates to methods of treatment and/or prevention by administering the compounds or combinations thereof. |